Aurobindo buys Portuguese firm for Rs 963 crore

To become leader in Portugal's generic drugs market

Aurobindo Pharma on Saturday announced the acquisition of Generis Farmaceutica, which operates in Portugal, from Magnum Capital Partners for an all-cash deal of €135 million (Rs 969.3 crore).  

The deal will be completed through Aurobindo Pharma’s step-down subsidiary, Agile Pharma, Netherlands. It will include a manufacturing facility in Amadora, Portugal, which has the capacity to produce 1.2 billion tablets or capsules annually. 

The acquisition also consolidates Aurobindo’s footprint in Portugal. It portfolio currently consists of Aurovitas, Unipessoal LDA and Aurobindo Pharma-Portugal. Generis has a wide portfolio of products, with a major share in therapeutic areas such as cardiovascular, central